HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nan Wang Anees Razzouk Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campwala, S. Z. Articles by Pai, R. G. Search for Related Content PubMed PubMed Citation Articles by Campwala, S. Z. Articles by Pai, R. G. Related Collections Coronary disease Valve disease

Eur J Cardiothorac Surg 2006;29:348-353
© 2006 Elsevier Science NL

Mitral regurgitation progression following isolated coronary artery bypass surgery: frequency, risk factors, and potential prevention strategies

^a Division of Cardiology, Loma Linda University Medical Center, Loma Linda, CA, United States
^b Division of Cardio-Thoracic Surgery, Loma Linda University Medical Center, Loma Linda, CA, United States

Received 22 August 2005; received in revised form 30 November 2005; accepted 6 December 2005.

^_* Corresponding author. Address: Division of Cardiology, University of Southern California, 1510 San Pablo Street, 322, Los Angeles, CA 90033, United States. Tel.: +1 323 442 6131; fax: +1 323 442 6133. (Email: rpai{at}usc.edu).

Background: Though de novo mitral regurgitation (MR) is frequently seen in patients who have undergone coronary artery bypass surgery (CABG), its incidence, predictors, and mechanisms are not known. Methods: Our surgical registry was screened for patients undergoing isolated CABG who had preoperative and postoperative resting echocardiograms performed at our institution with 2+ MR preoperatively. This yielded 438 patients. Progression to 3–4+ MR post-CABG was correlated with clinical, electrocardiographic, echocardiographic, and operative variables. Results: New 3–4+ MR developed in 11 (10%) of the 108 patients with no prior MR, 21 of the 180 (12%) patients with pre-CABG 1+ MR, and 37 of the 150 (25%) patients with pre-CABG 2+ MR. MR progression correlated with female gender (42% vs 27%, p = 0.01), history of renal insufficiency (12% vs 5%, p = 0.05), prior-CABG (30% vs 17%, p = 0.01), lack of beta-blocker use (19% vs 35%, p = 0.008), lower incidence of significant PDA stenosis grafted (88% vs 98%, p = 0.003), lower preoperative LVEF (42 ± 19% vs 50 ± 17%, p = 0.001), larger LV size (p = 0.01), pre-CABG MR grade (p = 0.0002), and pre-CABG presence of LBBB block (20% vs 4%, p < 0.0001). Independent predictors of MR progression, pre-CABG, were female gender (p = 0.002), history of renal insufficiency (p = 0.05), lack of beta-blocker use (p = 0.006), MR grade (p = 0.02), and presence of LBBB (p = 0.005). Conclusion: Development of significant MR following isolated CABG is common and may be related to incomplete myocardium revascularization, especially in the PDA area and LV remodeling. Preoperative, beta-blocker use may be protective against its development.

Key Words: CABG • MR

This article has been cited by other articles:

				W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text]

				A. R. Srivastava, A. Banerjee, S. Jacob, and J. Dunning Should patients undergoing coronary artery bypass grafting with mild to moderate ischaemic mitral regurgitation also undergo mitral valve repair or replacement? Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 538 - 546. [Abstract] [Full Text] [PDF]

				M. J. Antunes Editorial comment: Mild-moderate ischemic mitral regurgitation: should it be treated together with CABG? Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 353 - 354. [Full Text] [PDF]